DFX Intelligence
Private Credit Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
E•• H•••••
H•••••care & Pharmaceuticalsgroup grade Aon a schedule nowsponsor unattributed
Principal held
at least $18.9M
sum of BDC pieces, a lower bound
Fair value
$21.5M
100c on cost, debt pieces
Unfunded
n/a
commitments not yet drawn
BDC lenders
2
2 on the latest quarter
Facilities
2
2 equity pieces beside them
Next maturity
Aug 7, 2030
no dated debt inside 24 months
On the tape since
Sep 30, 2024
latest Jun 30, 2026
Events
1
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien | at least $18.9M | 100c | SOFR+550 bp | Aug 7, 2030 | 2 |
| first lien revolver first lien | unknown | n/a | Aug 7, 2030 | 2 |
Lenders
every BDC piece at the latest quarter end
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| B••• C•••••• P•••••• C••••• | revolver first lien First Lien Senior Secured Loan - Revolver Maturity Date 8/7/2030 | n/a | $-18,000 | |
| B••• C•••••• P•••••• C••••• | equity equity Equity Interest | $1.1M | $957,000 85c | |
| B••• C•••••• P•••••• C••••• | term loan first lien First Lien Senior Secured Loan SOFR Floor 1.00% Spread 5.50% Interest Rate 9.23% Maturity | $8.2M | $8.1M 100c | SOFR+550 bp |
| B••• C•••••• S•••••••• F••••••• I••• | equity equity Equity Interest | $2.2M | $1.9M 85c | |
| B••• C•••••• S•••••••• F••••••• I••• | unstated lien unstated Acquisition Date 8/7/2024 | n/a | n/a | |
| B••• C•••••• S•••••••• F••••••• I••• | revolver first lien First Lien Senior Secured Loan - Revolver Maturity Date 8/7/2030 | n/a | $-34,000 | |
| B••• C•••••• S•••••••• F••••••• I••• | term loan first lien First Lien Senior Secured Loan SOFR Floor 1.00% Spread 5.50% Interest Rate 9.23% Maturity | $10.7M | $10.6M 100c | SOFR+550 bp |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 2 | $18.9M | $18.7M | 99c | 0 |
| Mar 31, 2026 | 2 | $24.0M | $23.7M | 100c | 0 |
| Dec 31, 2025 | 2 | $24.0M | $24.0M | 101c | 0 |
| Sep 30, 2025 | 2 | $24.1M | $24.1M | 101c | 0 |
| Jun 30, 2025 | 2 | $24.1M | $24.1M | 101c | 0 |
| Mar 31, 2025 | 2 | $24.2M | $24.2M | 101c | 0 |
| Dec 31, 2024 | 2 | $29.3M | $28.9M | 100c | 0 |
| Sep 30, 2024 | 1 | $35.6M | $35.3M | 100c | 0 |
What changed
- New lender joined a facilityDec 31, 2024
- New lender joined a facilityDec 31, 2024
- New borrower on a BDC scheduleSep 30, 2024
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- E•• H•••••derivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 2 BDCsderived
- Industry
- H•••••care & Pharmaceuticalsreportedas one filer wrote it